Everest Medicines Statistics

Total Valuation

HKG:1952 has a market cap or net worth of HKD 15.05 billion. The enterprise value is 13.96 billion.

Market Cap	15.05B
Enterprise Value	13.96B

Important Dates

The next estimated earnings date is Monday, August 25, 2025.

Earnings Date	Aug 25, 2025
Ex-Dividend Date	n/a

Share Statistics

HKG:1952 has 324.43 million shares outstanding. The number of shares has increased by 2.51% in one year.

Current Share Class	n/a
Shares Outstanding	324.43M
Shares Change (YoY)	+2.51%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	1.17%
Owned by Institutions (%)	11.38%
Float	210.76M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	20.02
PB Ratio	3.47
P/TBV Ratio	7.78
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-12.60
EV / Sales	18.56
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-17.61

Financial Position

The company has a current ratio of 2.54, with a Debt / Equity ratio of 0.14.

Current Ratio	2.54
Quick Ratio	2.51
Debt / Equity	0.14
Debt / EBITDA	n/a
Debt / FCF	-0.77
Interest Coverage	-35.16

Financial Efficiency

Return on equity (ROE) is -23.04% and return on invested capital (ROIC) is -9.60%.

Return on Equity (ROE)	-23.04%
Return on Assets (ROA)	-9.09%
Return on Invested Capital (ROIC)	-9.60%
Return on Capital Employed (ROCE)	-18.73%
Revenue Per Employee	1.13M
Profits Per Employee	-1.67M
Employee Count	665
Asset Turnover	0.13
Inventory Turnover	10.77

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +94.96% in the last 52 weeks. The beta is 1.70, so HKG:1952's price volatility has been higher than the market average.

Beta (5Y)	1.70
52-Week Price Change	+94.96%
50-Day Moving Average	50.39
200-Day Moving Average	35.91
Relative Strength Index (RSI)	43.13
Average Volume (20 Days)	6,096,851

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, HKG:1952 had revenue of HKD 752.03 million and -1.11 billion in losses. Loss per share was -3.45.

Revenue	752.03M
Gross Profit	562.83M
Operating Income	-830.28M
Pretax Income	-1.11B
Net Income	-1.11B
EBITDA	-713.04M
EBIT	-830.28M
Loss Per Share	-3.45

Full Income Statement

Balance Sheet

The company has 1.71 billion in cash and 612.54 million in debt, giving a net cash position of 1.09 billion or 3.37 per share.

Cash & Cash Equivalents	1.71B
Total Debt	612.54M
Net Cash	1.09B
Net Cash Per Share	3.37
Equity (Book Value)	4.33B
Book Value Per Share	13.36
Working Capital	1.30B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -723.12 million and capital expenditures -69.60 million, giving a free cash flow of -792.72 million.

Operating Cash Flow	-723.12M
Capital Expenditures	-69.60M
Free Cash Flow	-792.72M
FCF Per Share	-2.44

Full Cash Flow Statement

Margins

Gross margin is 74.84%, with operating and profit margins of -110.41% and -147.36%.

Gross Margin	74.84%
Operating Margin	-110.41%
Pretax Margin	-147.36%
Profit Margin	-147.36%
EBITDA Margin	-94.82%
EBIT Margin	-110.41%
FCF Margin	n/a

Dividends & Yields

HKG:1952 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.51%
Shareholder Yield	-2.51%
Earnings Yield	-7.36%
FCF Yield	-5.27%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

HKG:1952 has an Altman Z-Score of 2.15. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.15
Piotroski F-Score	n/a